Treatment of localized epidermodysplasia verruciformis with tacalcitol ointment

International Journal of Dermatology

Volumn 41, Issue 11, 2002, Pages 817-820

  Hayashi, Junko ^a,b   Matsui, Chihiro ^a,b   Mitsuishi, Tsuyoshi ^a,b   Kawashima, Makoto ^a,b   Morohashi, Masaaki ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; ETRETINATE; TACALCITOL; VIRUS ANTIBODY; VIRUS DNA;

AGAR GEL ELECTROPHORESIS; AGED; ANAMNESIS; ARTICLE; BOWEN DISEASE; BREAST BIOPSY; BREAST SURGERY; BREAST TUMOR; CASE REPORT; CELL NUCLEUS; CELL PROLIFERATION; DERMIS; DNA EXTRACTION; DNA SEQUENCE; DRUG CHOICE; DRY LIP; EPIDERMODYSPLASIA VERRUCIFORMIS; EPITHELIUM TUMOR; ERYTHEMA; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; INFLAMMATORY INFILTRATE; JAPAN; KERATINIZATION; KERATINOCYTE; LIP DISEASE; MICROSCOPY; MITOSIS; NUCLEIC ACID BASE SUBSTITUTION; OINTMENT; OPEN READING FRAME; PLASMID; POLYMERASE CHAIN REACTION; SKIN BURNING SENSATION; SQUAMOUS CELL CARCINOMA; STAINING; TUBERCULIN TEST; WART VIRUS;

AGED; DERMATOLOGIC AGENTS; DIHYDROXYCHOLECALCIFEROLS; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; OINTMENTS; TREATMENT OUTCOME;

EID: 0036857443     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01642.x     Document Type: Article

References (18)

1. Bowen JT. Precancerous dermatoses: A study of two cases of chronic atypical epithelial proliferation. J Cutan Dis 1912; 30: 241-255.
2. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988; 10: 122-163.
3. Schwartz RA, Janniger CK. Bowenoid papulosis. J Am Acad Dermatol 1991; 24 (2 Part 1): 261-264.
4. Moy RL, Eliezri YD, Nuovo GJ, et al. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. J Am Med Assoc 1989; 261 (18): 2669-2673.
5. Eliezri YD, Silverstein SJ, Nuovo GJ. Occurrence of human papillomavirus type 16 DNA in cutaneous squamous and basal cell neoplasms. J Am Acad Dermatol 1990; 23 (5 Part 1): 836-842.
6. Kettler AH, Rutledge M, Tschen JA, Buffone G. Detection of human papillomavirus in nongenital Bowen's disease by in situ DNA hybridization. Arch Dermatol 1990; 126 (6): 777-781.
7. Guitart J, Bergfeld WF, Tuthill RJ, et al. Squamous cell carcinoma of the nail bed: A clinicopathological study of 12 cases. Br J Dermatol 1990; 123 (2): 215-222.
8. Ashinoff R, Li JJ, Jacobson M, et al. Detection of human papillomavirus DNA in squamous cell carcinoma of the nail bed and finger determined by polymerase chain reaction. Arch Dermatol 1991; 127 (12): 1813-1818.
9. McGrae JD, Greer CE, Manos MM. Multiple Bowen's disease of the fingers associated with human papilloma virus type 16. Int J Dermatol 1993; 32 (2): 104-107.
10. Jablonska S, Majewski S. Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Topics Microbiol Immunol 1994; 186: 157-175.
11. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131 (11): 1312-1318.
12. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997; 36 (5 Part 1): 659-685, 686-688.
13. Orth G. Epidermodysplasia verruciformis. In: Salzman HP, Howley PM, eds. The Papovaviridae. London: Plenum Press, 1987; 2: 101-243.
14. Androphy EJ, Dvoretzky I, Maluish AE, et al. Response of warts in epidermodysplasia verruciformis to treatment with systemic and intralesional alpha interferon. J Am Acad Dermatol 1984; 11 (2 Part 1): 197-202.
15. Blanchet-Bardon C, Lutzner MA. Interferon and retinoid treatment of warts. Clin Dermatol 1985; 3 (4): 195-199.
16. Lippman SM, Kavanagh JJ. Paredes-Espinoza M, et al. 13-cis-retinoic acid plus interferon alpha-2a: Highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 1992; 84 (4): 241-245.
17. Majewski S, Skopinska M, Bollag W, Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet 1994; 344 (8935): 1510-1511.
18. 3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effect of retinoids. Cancer Lett 1995; 89 (1): 117-124.